<DOC>
	<DOC>NCT02132663</DOC>
	<brief_summary>This clinical trial will evaluate an investigational infant formula with an alternate source of DHA to determine if it provides normal growth and if it is well tolerated by term infants as compared to a marketed routine infant formula.</brief_summary>
	<brief_title>The Effects on Growth and Tolerance of a Routine Infant Formula Fed to Term Infants</brief_title>
	<detailed_description />
	<criteria>Singleton, 1014 days of age at randomization Term infant with birth weight of a minimum of 2500 grams Solely formula fed Signed Informed Consent and Protected Health Information History of underlying metabolic or chronic disease or immunocompromised Feeding difficulties or formula intolerance</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>14 Days</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>